Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
for entities : Abbvie inc. save search
AbbVie Announces Late-Breaking Data at AAN Supporting Long-Term Safety and Efficacy of Atogepant (QULIPTA®) for Preventive Treatment of Migraine
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -1.92%
H: 0.0%
C: 0.0%
qulipta abbvie treatment for migraine
Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting
Published: 2024-04-08 (Crawled : 12:30) - globenewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.77%
H: 1.63%
C: 0.35%
CHRS | $2.155 -2.05% -2.09% 1.4M
|
Health Technology
|
| O: 0.82%
H: 3.88%
C: 2.45%
chs-1000 preclinical for meeting
Global Highly Potent API (Active Pharmaceutical Ingredient) Industry Research 2023-2033: Advancements in Containment Technologies, and Increasing Investment for Manufacturing Units
Published: 2024-03-28 (Crawled : 01:00) - prnewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.36%
H: 0.72%
C: 0.61%
research global
Flooring Market size to record USD 84.98 bn growth from 2024-2028, Increasing demand for waterproof flooring is one of the key market trends, Technavio
Published: 2024-03-27 (Crawled : 23:00) - prnewswire.com
ITOCF | $44.056 3.01% 5.3K
|
Distribution Services
|
| O: 0.21%
H: 0.09%
C: 0.09%
ITOCY | $87.53 0.0% 78K
|
Real Estate and Rental and Leas...
|
| O: -0.75%
H: 0.14%
C: -0.18%
RPM | $107.89 -0.47% 0.0% 420K
|
Process Industries
|
| O: -0.05%
H: 0.52%
C: -0.97%
AWI | $115.65 -0.73% 0.0% 220K
|
Producer Manufacturing
|
| O: 0.06%
H: 0.5%
C: -0.26%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.36%
H: 0.72%
C: 0.61%
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
one key growth market
U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients
Published: 2024-03-22 (Crawled : 19:00) - prnewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
| Email alert
Add to watchlist
elahere drug approval food cancer grants
Waste Management Market to grow by USD 167.1 billion, laws in Europe for recycling waste to boost market growth, Technavio
Published: 2024-03-22 (Crawled : 18:00) - prnewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
| Email alert
Add to watchlist
ABT | $109.21 0.29% 0.34% 7.3M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
| Email alert
Add to watchlist
europe management market
Global OTC Artificial Tears Analysis Report 2023-2030: The Influence of Smart Technologies, Market Positioned for Continued Expansion Amid Growing Focus on Eye Wellness
Published: 2024-03-21 (Crawled : 00:00) - prnewswire.com
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.17%
H: 0.28%
C: -0.01%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
BHC | $8.74 1.28% 0.11% 2.5M
|
Health Technology
|
| O: -0.74%
H: 1.54%
C: 1.38%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.16%
H: 0.0%
C: 0.0%
report expansion global wellness smart growing eye market
Alvotech Reports Financial Results for Full Year 2023 and Provides a Business Update
Published: 2024-03-20 (Crawled : 20:00) - globenewswire.com
ALVO | $12.69 1.52% 1.5% 370K
|
n/a
|
| O: -1.58%
H: 1.87%
C: 0.53%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
KMDA | $5.15 -0.96% -0.97% 16K
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: -1.86%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: 0.58%
H: 1.2%
C: 0.84%
business year update financial results
Global Angina Pectoris Drugs Market Set for Growth Amid Advancements in Healthcare Infrastructure
Published: 2024-03-11 (Crawled : 23:00) - prnewswire.com
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: 2.01%
H: 0.0%
C: -2.01%
JNJ | $144.45 -2.13% 0.03% 13M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.02%
H: 0.79%
C: 0.79%
LLY | $746.74 -0.54% 1.01% 2.5M
|
Health Technology
|
| O: 0.9%
H: 2.03%
C: 1.89%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 1.04%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -0.19%
H: 0.22%
C: -0.21%
global set growth market
AbbVie and OSE Immunotherapeutics Announce Partnership to Develop a Novel Monoclonal Antibody for the Treatment of Chronic Inflammation
Published: 2024-02-28 (Crawled : 06:00) - prnewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.6%
H: 0.02%
C: -1.03%
partnership abbvie antibody treatment
U.S. Food and Drug Administration (FDA) Grants Priority Review of Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma (FL)
Published: 2024-02-27 (Crawled : 13:30) - biospace.com/
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
epkinly drug review food grants
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma
Published: 2024-02-27 (Crawled : 01:00) - globenewswire.com
GNMSF | $282.004 3.83% 210
|
Health Technology
|
| O: -0.28%
H: 1.46%
C: 1.46%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
GMAB | $29.42 -0.31% -0.31% 340K
|
Health Technology
|
| O: -1.6%
H: 1.11%
C: 0.41%
epkinly fda license review application
AbbVie and Tentarix Announce Collaboration to Develop Conditionally-Active, Multi-Specific Biologics for Oncology and Immunology
Published: 2024-02-22 (Crawled : 13:00) - prnewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.88%
H: 1.46%
C: 1.13%
abbvie collaboration immunology
Biologic Therapeutics Market to Increase by USD 286.12 billion during 2022-2027, North America to account for 57% of the growth - Technavio
Published: 2024-02-07 (Crawled : 08:00) - prnewswire.com
AZNCF | $135.94 -4.19% 770
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.41%
H: 0.0%
C: 0.0%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.09%
H: 0.39%
C: -0.36%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: 0.43%
H: 0.67%
C: 0.21%
BAX | $39.57 -1.17% -0.56% 2.7M
|
Health Technology
|
| O: 0.21%
H: 0.24%
C: -1.04%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
BMRN S | $90.9 -0.67% -0.67% 1.2M
|
Health Technology
|
| O: -0.38%
H: 1.79%
C: 0.22%
AZN | $68.27 -0.67% -0.67% 3.8M
|
Health Technology
|
| O: -0.4%
H: 0.19%
C: -0.33%
AMGN | $265.64 0.05% 0.05% 2M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -6.22%
america therapeutics growth market
Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases
Published: 2024-02-06 (Crawled : 17:00) - prnewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
abbvie license tumors cell expansion agreement
Heart Transplantation Therapeutics Market Projected for USD 135.37 Million Growth between 2024 and 2028: Market to Focus on Newer Techniques for Heart Transplantation - Technavio
Published: 2024-02-02 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.48 43.47% 1.7K
|
Health Technology
|
| O: -3.89%
H: 0.0%
C: 0.0%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: -4.76%
H: 7.0%
C: 3.18%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: -0.05%
H: 0.59%
C: 0.27%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: 3.59%
H: 0.0%
C: 0.0%
million heart therapeutics growth market
Antimicrobial Therapeutics Market to grow by USD 51.4 billion from 2022 to 2027, North America accounts for 38% of market growth- Technavio
Published: 2024-01-17 (Crawled : 06:00) - prnewswire.com
CSLLY | $89.5 3.3% 44K
|
n/a
|
| O: -0.64%
H: 0.54%
C: 0.54%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
SNYNF | $92.966 -2.18% 630
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: 0.0%
ALPMY | $9.2715 -1.11% 500K
|
Manufacturing
|
| O: -1.74%
H: 0.0%
C: -1.35%
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
|
| O: 0.49%
H: 0.18%
C: 0.04%
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
|
| O: -0.08%
H: 0.1%
C: -0.18%
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.15%
H: 0.74%
C: 0.18%
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
|
| O: 0.45%
H: 0.06%
C: -0.5%
america therapeutics market
AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson's Disease in the European Union
Published: 2024-01-09 (Crawled : 07:00) - prnewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
|
| O: -0.56%
H: 1.26%
C: 0.55%
produodopa disease abbvie parkinson's advanced living
Pharmaceutical Contract Manufacturing Market to grow by USD 58 billion from 2022 to 2027, North America to account for 41% of market growth - Technavio
Published: 2024-01-05 (Crawled : 23:00) - prnewswire.com
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
| Email alert
Add to watchlist
BAX | $39.57 -1.17% -0.56% 2.7M
|
Health Technology
| Email alert
Add to watchlist
TMO | $554.55 -0.6% 0.0% 1M
|
Health Technology
| Email alert
Add to watchlist
GIKLY | $4.56 132.75% 260
|
Manufacturing
| Email alert
Add to watchlist
GIFLF | $8.46 42.22% 610
|
Health Technology
| Email alert
Add to watchlist
america contract growth market
Active Pharmaceutical Ingredients Market is to grow by USD 86.47 billion from 2023 to 2028, Asia to account for 52% of market growth - Technavio
Published: 2024-01-05 (Crawled : 22:00) - prnewswire.com
GSK | $39.95 -1.36% 0.0% 2.4M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | $92.966 -2.18% 630
|
Health Technology
| Email alert
Add to watchlist
ABBV | $162.54 0.54% 0.0% 4.8M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
TMO | $554.55 -0.6% 0.0% 1M
|
Health Technology
| Email alert
Add to watchlist
AAPL | $169.34 -1.94% -1.98% 73M
|
Electronic Technology
| Email alert
Add to watchlist
NVS | $93.2 -1.28% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
TEVJF | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
GOOG | $155.98 -0.22% -0.22% 15M
|
Technology Services
| Email alert
Add to watchlist
SNY | $45.81 -0.93% -0.94% 1.4M
|
Health Technology
| Email alert
Add to watchlist
VTRS | $11.12 -1.77% -1.8% 6.8M
|
Health Technology
| Email alert
Add to watchlist
GOOGL | $154.4 -0.3% -0.3% 21M
|
Technology Services
| Email alert
Add to watchlist
active asia growth market
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
WISA 4 | $6.06 246.29% 71.12% 200M
|
Electronic Technology
VIAO | $0.265 -13.96% 35.85% 960K
|
Electronic Technology
JAGX | $0.178 49.83% 33.26% 600M
|
Health Technology
SXTC | $1.68 43.59% 30.36% 34M
|
Health Technology
DYNT | $0.531 43.36% 30.24% 22M
|
Health Technology
KA | $0.4796 41.06% 29.11% 5.3M
|
Manufacturing
PALI | $5.86 40.87% 29.01% 29M
|
Manufacturing
CLNN | $0.319 -3.74% 28.75% 6.3M
|
BSGM | $1.52 38.18% 27.63% 3.3M
|
Health Technology
MCBC | $13.67 37.66% 27.36% 2.2M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.